S1P Receptor Modulators

Cat.No.	Product Name	Information	Product Use Citations
S5950	Fingolimod (FTY-720)	Fingolimod (FTY-720) is a sphingosine 1-phosphate receptor modulator used for the treatment of relapsing-remitting multiple sclerosis.	Nat Commun, 2024, 15(1):6970 Ther Adv Neurol Diso, 2024, 17:17562864241300047 Oncol Res, 2023, 31(6):867-875
S7952	Ozanimod	Ozanimod is a selective oral S1P Receptor 1 modulator. Phase 3.	Nat Commun, 2025, 16(1):1826 Front Immunol, 2024, 15:1230735 FASEB J, 2022, 36(2):e22132
S8241	Ponesimod (ACT-128800)	Ponesimod (ACT-128800) is an orally active, selective sphingosine-1-phosphate receptor 1 (S1P1) immunomodulator with EC50 of 5.7 nM.	Cancers (Basel), 2024, 16(3)574 EBioMedicine, 2023, 94:104713 Int J Mol Sci, 2022, 23(18)10311

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S5950

Fingolimod (FTY-720)

Fingolimod (FTY-720) is a sphingosine 1-phosphate receptor modulator used for the treatment of relapsing-remitting multiple sclerosis.

Nat Commun, 2024, 15(1):6970

Ther Adv Neurol Diso, 2024, 17:17562864241300047

Oncol Res, 2023, 31(6):867-875

S7952

Ozanimod

Ozanimod is a selective oral S1P Receptor 1 modulator. Phase 3.

Nat Commun, 2025, 16(1):1826

Front Immunol, 2024, 15:1230735

FASEB J, 2022, 36(2):e22132

S8241

Ponesimod (ACT-128800)

Ponesimod (ACT-128800) is an orally active, selective sphingosine-1-phosphate receptor 1 (S1P1) immunomodulator with EC50 of 5.7 nM.

Cancers (Basel), 2024, 16(3)574

EBioMedicine, 2023, 94:104713

Int J Mol Sci, 2022, 23(18)10311